Abstract
Focal Points
■ Pharmacists’ reasons for not being in favour of the over-the-counter (OTC) statin were multifactorial and provide indications of how their misgivings might be addressed
■ Provision of a satisfactory and convincing evidence base might improve acceptance by the pharmaceutical community, of future prescription – only medicine (POM) to pharmacy medicine (P) switches
Original language | English |
---|---|
Pages (from-to) | B49-B50 |
Journal | International Journal of Pharmacy Practice |
Volume | 14 |
Issue number | S2 |
DOIs | |
Publication status | Published - Sept 2006 |